Cullinan Associates Inc Abbott Laboratories Transaction History

Cullinan Associates Inc

  • $1.81 Billion
  • Q3 2024

A detailed history of Cullinan Associates Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Cullinan Associates Inc holds 43,794 shares of ABT stock, worth $5 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
43,794
Previous 51,494 14.95%
Holding current value
$5 Million
Previous $5.35 Million 6.69%
% of portfolio
0.28%
Previous 0.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$100.07 - $118.13 $770,539 - $909,601
-7,700 Reduced 14.95%
43,794 $4.99 Million
Q2 2024

Jul 10, 2024
BUY
$100.73 - $112.44 $100,730 - $112,440
1,000 Added 1.98%
51,494 $5.35 Million
Q1 2024

Apr 18, 2024
SELL
$109.52 - $120.96 $3.02 Million - $3.34 Million
-27,586 Reduced 35.33%
50,494 $5.74 Million
Q4 2023

Jan 24, 2024
SELL
$90.19 - $110.4 $1.67 Million - $2.04 Million
-18,471 Reduced 19.13%
78,080 $8.59 Million
Q3 2023

Oct 11, 2023
SELL
$95.53 - $114.62 $131,258 - $157,487
-1,374 Reduced 1.4%
96,551 $9.35 Million
Q2 2023

Jul 14, 2023
SELL
$100.78 - $112.29 $320,984 - $357,643
-3,185 Reduced 3.15%
97,925 $10.7 Million
Q1 2023

Apr 05, 2023
SELL
$96.86 - $114.01 $750,761 - $883,691
-7,751 Reduced 7.12%
101,110 $10.2 Million
Q4 2022

Jan 11, 2023
SELL
$95.06 - $111.52 $516,270 - $605,665
-5,431 Reduced 4.75%
108,861 $12 Million
Q3 2022

Oct 19, 2022
BUY
$96.76 - $112.03 $149,590 - $173,198
1,546 Added 1.37%
114,292 $11.1 Million
Q2 2022

Jul 08, 2022
SELL
$102.07 - $123.37 $817,682 - $988,317
-8,011 Reduced 6.63%
112,746 $12.3 Million
Q1 2022

Apr 21, 2022
SELL
$114.02 - $139.04 $61,798 - $75,359
-542 Reduced 0.45%
120,757 $14.3 Million
Q4 2021

Jan 07, 2022
BUY
$115.53 - $141.46 $2.29 Million - $2.8 Million
19,807 Added 19.52%
121,299 $17.1 Million
Q3 2021

Oct 08, 2021
BUY
$116.66 - $129.06 $396,877 - $439,062
3,402 Added 3.47%
101,492 $12 Million
Q2 2021

Jul 07, 2021
BUY
$105.79 - $124.53 $1.23 Million - $1.44 Million
11,600 Added 13.41%
98,090 $11.4 Million
Q1 2021

Apr 20, 2021
SELL
$108.84 - $128.23 $2.61 Million - $3.07 Million
-23,950 Reduced 21.69%
86,490 $10.4 Million
Q4 2020

Jan 14, 2021
BUY
$105.0 - $114.42 $918,750 - $1 Million
8,750 Added 8.6%
110,440 $12.1 Million
Q3 2020

Oct 09, 2020
BUY
$91.64 - $111.29 $192,444 - $233,709
2,100 Added 2.11%
101,690 $11.1 Million
Q2 2020

Jul 07, 2020
SELL
$76.57 - $98.0 $42,496 - $54,390
-555 Reduced 0.55%
99,590 $9.11 Million
Q1 2020

Apr 01, 2020
BUY
$62.82 - $91.86 $786,820 - $1.15 Million
12,525 Added 14.29%
100,145 $7.9 Million
Q4 2019

Jan 15, 2020
BUY
$78.51 - $87.4 $114,232 - $127,167
1,455 Added 1.69%
87,620 $7.61 Million
Q3 2019

Oct 01, 2019
BUY
$81.84 - $88.74 $1.8 Million - $1.95 Million
21,935 Added 34.15%
86,165 $7.21 Million
Q2 2019

Jul 16, 2019
SELL
$72.88 - $85.0 $131,184 - $153,000
-1,800 Reduced 2.73%
64,230 $5.4 Million
Q1 2019

Apr 30, 2019
BUY
$66.22 - $80.06 $987,340 - $1.19 Million
14,910 Added 29.17%
66,030 $5.28 Million
Q4 2018

Jan 11, 2019
BUY
$65.56 - $74.27 $2.4 Million - $2.71 Million
36,550 Added 250.86%
51,120 $3.7 Million
Q3 2018

Oct 19, 2018
SELL
$60.81 - $73.36 $72,972 - $88,032
-1,200 Reduced 7.61%
14,570 $1.07 Million
Q2 2018

Jul 09, 2018
SELL
$57.57 - $63.54 $8,750 - $9,658
-152 Reduced 0.95%
15,770 $962,000
Q1 2018

Apr 27, 2018
SELL
$56.27 - $63.62 $4.18 Million - $4.73 Million
-74,302 Reduced 82.35%
15,922 $954,000
Q4 2017

Jan 17, 2018
SELL
$53.68 - $57.47 $9.49 Million - $10.2 Million
-176,774 Reduced 66.21%
90,224 $5.15 Million
Q3 2017

Oct 16, 2017
BUY
$48.06 - $53.64 $12.8 Million - $14.3 Million
266,998
266,998 $14.2 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email